BUSINESS● LOWSep 4 · Sep 4, 2026, 9:00 PM
Ionis Pharmaceuticals falls after Pelacarsen fails key Phase 3 heart trial
Seeking Alpha Tech · global
Ionis Pharmaceuticals experienced a decline after its drug Pelacarsen failed a key Phase 3 heart trial, impacting the company's market performance and drug development efforts.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS29m agoIndia bars sugar-based ethanol in 2026-27 tender, cuts maize incentiveThe HinduBUSINESS34m agoFood Pantry Patrons Face ‘Too Much Month at the End of Their Money’NYT US